Effects of flurbiprofen pretreatment on global cerebral ischemia-reperfusion injury in rats
Huisheng Wu, Danyan Liu
Abstract
Huisheng Wu, Danyan Liu
Abstract
Objective To investigate the effects of pretreatment with flurbiprofen on global cerebral ischemia-repeffasion (IR) injury in rats and the mechanism involved. Methods Eighty-four male SD rats weighing 200-350 g were randomly divided into 4 groups (n = 21 each): group Ⅰ sham operation (group S); group Ⅱ global cerebral IR (group IR); group Ⅲ flurbiprofen 5 mg/kg + global cerebral IR (group F_1) and group Ⅳ flurbiprofen 10 mg/kg + global cerebral IR (group F_2). Global cerebral ischemia was induced by 20 rain occlusion of bilateral common carotid arteries combined with hypotension (MAP maintained at 35-45 mm Hg). In group F_1 and F_2 flnrbiprofen 5 and 10 mg/kg was injected iv at 15 min before ischemia respectively. The neurological deficit score (NDS) was assessed (0=normal, 100 = brain death) at 6 h (T_1), 24 h (T_2) and 72 h (T_3) of reperfusion by the same observer. Blood samples were taken from left internal jugular vein. And then the animals were killed and brains removed for determination of serum concentrations of TNF-α and IL-1β(using radioimmunoassay), expression of nuclear factor-kappa B (NF-κB) mRNA and intercellular adhesion molecule-1 (ICAM-1) mRNA in hippocampus (by RT-PCR), and microscopic examination. Results Compared with group S, NDS at T_(1-3) was significantly increased, expression of NF-κB mRNA and ICAM-1 mRNA at T_(1-3) was up-regulated and serum concentrations of TNF-α at T_(1,2)and IL-1β at T_(1-3) were significantly increased in the other three groups (P < 0.05 or 0.01). Compared with group IR, NDS at T_(1-3) was significantly decreased, expression of NF-κB mRNA and ICAM-I mRNA at T_(1-3) was down-regulated and serum concentrations of TNF-α at T_(1,2)and IL-1βat T_(1-3) were significantly decreased in group F_(1,2) (P < 0.05 or 0.01). The expression of ICAM-1 mRNA at T_(2,3) was down-regulated and serum concentrations of IL-1β at T_2 significantly decreased in group F_2 compared with group F_1(P < 0.05 or 0.01). The histologic damage was significantly slighter in group F_(1,2) than in group IR and in group F_2 than in group F_1. Conclusion Pretreatment with flurbiprofen can attenuate global cerebral IR injury through inhibition of the inflammatory reaction in hippocampus in a dose-dependent manner in rats. Key words: Flurbiprofen; Brain; Reperfusion injury; Hippocampus
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To investigate the effects of pretreatment with flurbiprofen on global cerebral ischemia-repeffasion (IR) injury in rats and the mechanism involved. Methods Eighty-four male SD rats weighing 200-350 g were randomly divided into 4 groups (n = 21 each): group Ⅰ sham operation (group S); group Ⅱ global cerebral IR (group IR); group Ⅲ flurbiprofen 5 mg/kg + global cerebral IR (group F_1) and group Ⅳ flurbiprofen 10 mg/kg + global cerebral IR (group F_2). Global cerebral ischemia was induced by 20 rain occlusion of bilateral common carotid arteries combined with hypotension (MAP maintained at 35-45 mm Hg). In group F_1 and F_2 flnrbiprofen 5 and 10 mg/kg was injected iv at 15 min before ischemia respectively. The neurological deficit score (NDS) was assessed (0=normal, 100 = brain death) at 6 h (T_1), 24 h (T_2) and 72 h (T_3) of reperfusion by the same observer. Blood samples were taken from left internal jugular vein. And then the animals were killed and brains removed for determination of serum concentrations of TNF-α and IL-1β(using radioimmunoassay), expression of nuclear factor-kappa B (NF-κB) mRNA and intercellular adhesion molecule-1 (ICAM-1) mRNA in hippocampus (by RT-PCR), and microscopic examination. Results Compared with group S, NDS at T_(1-3) was significantly increased, expression of NF-κB mRNA and ICAM-1 mRNA at T_(1-3) was up-regulated and serum concentrations of TNF-α at T_(1,2)and IL-1β at T_(1-3) were significantly increased in the other three groups (P < 0.05 or 0.01). Compared with group IR, NDS at T_(1-3) was significantly decreased, expression of NF-κB mRNA and ICAM-I mRNA at T_(1-3) was down-regulated and serum concentrations of TNF-α at T_(1,2)and IL-1βat T_(1-3) were significantly decreased in group F_(1,2) (P < 0.05 or 0.01). The expression of ICAM-1 mRNA at T_(2,3) was down-regulated and serum concentrations of IL-1β at T_2 significantly decreased in group F_2 compared with group F_1(P < 0.05 or 0.01). The histologic damage was significantly slighter in group F_(1,2) than in group IR and in group F_2 than in group F_1. Conclusion Pretreatment with flurbiprofen can attenuate global cerebral IR injury through inhibition of the inflammatory reaction in hippocampus in a dose-dependent manner in rats. Key words: Flurbiprofen; Brain; Reperfusion injury; Hippocampus
Key concepts: Ischemia, Flurbiprofen, Reperfusion injury, Anesthesia, Medicine, Radioimmunoassay, Internal medicine, Hippocampus